inactivated rotavirus vaccine
Vaccineexperimental
Clinical trial activity
5 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 3, 2020 (NCT04626856)
Timeline
Indications
Mechanism of action
- RotavirusImmunity, active
Rotavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06962904 | Phase 1 | Jul 7, 2025 | Centers for Disease Control and Prevention (CDC), Emory University, Micron Biomedical, Inc, University of Cincinnati |
| NCT06485258 | Phase 1 | Aug 5, 2024 | Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention (CDC), Emory University, University of Cincinnati |
| NCT06080906 | Phase 2 | Oct 17, 2023 | Chinese Academy of Medical Sciences, Government of China |
| NCT06350058 | Phase 1 | Aug 3, 2021 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
| NCT04626856 | Phase 1 | Dec 3, 2020 | Chinese Academy of Medical Sciences, Government of China |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centers for Disease Control and Prevention (CDC) | Government | 2 | 2 | 1 | 2024 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 2 | 2 | 2020 |
| Emory University | Academic/Hospital | 2 | 0 | 1 | 2024 |
| Government of China | Government | 2 | 0 | 2 | 2020 |
| University of Cincinnati | Academic/Hospital | 2 | 0 | 1 | 2024 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | For profit | 1 | 1 | 1 | 2021 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Micron Biomedical, Inc | For profit | 1 | 0 | 1 | 2025 |
8 organizations
Page 1 / 1